Cargando…

Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography

[Image: see text] We describe a novel fragment library termed fragments of life (FOL) for structure-based drug discovery. The FOL library includes natural small molecules of life, derivatives thereof, and biaryl protein architecture mimetics. The choice of fragments facilitates the interrogation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies, Douglas R., Mamat, Bjorn, Magnusson, Olafur T., Christensen, Jeff, Haraldsson, Magnus H., Mishra, Rama, Pease, Brian, Hansen, Erik, Singh, Jasbir, Zembower, David, Kim, Hidong, Kiselyov, Alex S., Burgin, Alex B., Gurney, Mark E., Stewart, Lance J.
Formato: Texto
Lenguaje:English
Publicado: American Chemical Society 2009
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2722745/
https://www.ncbi.nlm.nih.gov/pubmed/19618939
http://dx.doi.org/10.1021/jm900259h
_version_ 1782170336536559616
author Davies, Douglas R.
Mamat, Bjorn
Magnusson, Olafur T.
Christensen, Jeff
Haraldsson, Magnus H.
Mishra, Rama
Pease, Brian
Hansen, Erik
Singh, Jasbir
Zembower, David
Kim, Hidong
Kiselyov, Alex S.
Burgin, Alex B.
Gurney, Mark E.
Stewart, Lance J.
author_facet Davies, Douglas R.
Mamat, Bjorn
Magnusson, Olafur T.
Christensen, Jeff
Haraldsson, Magnus H.
Mishra, Rama
Pease, Brian
Hansen, Erik
Singh, Jasbir
Zembower, David
Kim, Hidong
Kiselyov, Alex S.
Burgin, Alex B.
Gurney, Mark E.
Stewart, Lance J.
author_sort Davies, Douglas R.
collection PubMed
description [Image: see text] We describe a novel fragment library termed fragments of life (FOL) for structure-based drug discovery. The FOL library includes natural small molecules of life, derivatives thereof, and biaryl protein architecture mimetics. The choice of fragments facilitates the interrogation of protein active sites, allosteric binding sites, and protein−protein interaction surfaces for fragment binding. We screened the FOL library against leukotriene A4 hydrolase (LTA4H) by X-ray crystallography. A diverse set of fragments including derivatives of resveratrol, nicotinamide, and indole were identified as efficient ligands for LTA4H. These fragments were elaborated in a small number of synthetic cycles into potent inhibitors of LTA4H representing multiple novel chemotypes for modulating leukotriene biosynthesis. Analysis of the fragment-bound structures also showed that the fragments comprehensively recapitulated key chemical features and binding modes of several reported LTA4H inhibitors.
format Text
id pubmed-2722745
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-27227452009-08-07 Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography Davies, Douglas R. Mamat, Bjorn Magnusson, Olafur T. Christensen, Jeff Haraldsson, Magnus H. Mishra, Rama Pease, Brian Hansen, Erik Singh, Jasbir Zembower, David Kim, Hidong Kiselyov, Alex S. Burgin, Alex B. Gurney, Mark E. Stewart, Lance J. J Med Chem [Image: see text] We describe a novel fragment library termed fragments of life (FOL) for structure-based drug discovery. The FOL library includes natural small molecules of life, derivatives thereof, and biaryl protein architecture mimetics. The choice of fragments facilitates the interrogation of protein active sites, allosteric binding sites, and protein−protein interaction surfaces for fragment binding. We screened the FOL library against leukotriene A4 hydrolase (LTA4H) by X-ray crystallography. A diverse set of fragments including derivatives of resveratrol, nicotinamide, and indole were identified as efficient ligands for LTA4H. These fragments were elaborated in a small number of synthetic cycles into potent inhibitors of LTA4H representing multiple novel chemotypes for modulating leukotriene biosynthesis. Analysis of the fragment-bound structures also showed that the fragments comprehensively recapitulated key chemical features and binding modes of several reported LTA4H inhibitors. American Chemical Society 2009-07-20 2009-08-13 /pmc/articles/PMC2722745/ /pubmed/19618939 http://dx.doi.org/10.1021/jm900259h Text en Copyright © 2009 American Chemical Society http://pubs.acs.org This is an open-access article distributed under the ACS AuthorChoice Terms & Conditions. Any use of this article, must conform to the terms of that license which are available at http://pubs.acs.org.
spellingShingle Davies, Douglas R.
Mamat, Bjorn
Magnusson, Olafur T.
Christensen, Jeff
Haraldsson, Magnus H.
Mishra, Rama
Pease, Brian
Hansen, Erik
Singh, Jasbir
Zembower, David
Kim, Hidong
Kiselyov, Alex S.
Burgin, Alex B.
Gurney, Mark E.
Stewart, Lance J.
Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography
title Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography
title_full Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography
title_fullStr Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography
title_full_unstemmed Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography
title_short Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography
title_sort discovery of leukotriene a4 hydrolase inhibitors using metabolomics biased fragment crystallography
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2722745/
https://www.ncbi.nlm.nih.gov/pubmed/19618939
http://dx.doi.org/10.1021/jm900259h
work_keys_str_mv AT daviesdouglasr discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography
AT mamatbjorn discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography
AT magnussonolafurt discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography
AT christensenjeff discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography
AT haraldssonmagnush discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography
AT mishrarama discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography
AT peasebrian discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography
AT hansenerik discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography
AT singhjasbir discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography
AT zembowerdavid discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography
AT kimhidong discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography
AT kiselyovalexs discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography
AT burginalexb discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography
AT gurneymarke discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography
AT stewartlancej discoveryofleukotrienea4hydrolaseinhibitorsusingmetabolomicsbiasedfragmentcrystallography